Abstract

Objective: To construct and validate a combined Nomogram model based on radiomic and semantic features to preoperatively classify serous and mucinous pathological types in patients with ovarian cystadenoma.Methods: A total of 103 patients with pathology-confirmed ovarian cystadenoma who underwent CT examination were collected from two institutions. All cases divided into training cohort (N = 73) and external validation cohort (N = 30). The CT semantic features were identified by two abdominal radiologists. The preprocessed initial CT images were used for CT radiomic features extraction. The LASSO regression were applied to identify optimal radiomic features and construct the Radscore. A Nomogram model was constructed combining the Radscore and the optimal semantic feature. The model performance was evaluated by ROC analysis, calibration curve and decision curve analysis (DCA).Result: Five optimal features were ultimately selected and contributed to the Radscore construction. Unilocular/multilocular identification was significant difference from semantic features. The Nomogram model showed a better performance in both training cohort (AUC = 0.94, 95%CI 0.86–0.98) and external validation cohort (AUC = 0.92, 95%CI 0.76–0.98). The calibration curve and DCA analysis indicated a better accuracy of the Nomogram model for classification than either Radscore or the loculus alone.Conclusion: The Nomogram model combined radiomic and semantic features could be used as imaging biomarker for classification of serous and mucinous types of ovarian cystadenomas.

Highlights

  • Epithelial neoplasm of the ovary accounts for 60% of all ovary tumors and can be classified as benign, borderline, or malignant [1]

  • The Nomogram model combined radiomic and semantic features could be used as imaging biomarker for classification of serous and mucinous types of ovarian cystadenomas

  • A total of 103 cases with pathologically confirmed ovarian cystadenoma were selected in the final cohort

Read more

Summary

Introduction

Epithelial neoplasm of the ovary accounts for 60% of all ovary tumors and can be classified as benign, borderline, or malignant [1]. Ovarian cystadenomas are the most common benign epithelial neoplasms. The two most common types of cystadenomas are serous (70%) and mucinous (25%), whereas endometrioid and clear cell cystadenoma are rare [2]. The radiological presentation of cystadenoma can be classified as serous or mucinous [2, 4]. Serous cystadenoma do not have mutations in either KRAS or BRAF and malignant transformation is rare [3]. KRAS mutations of mucinous cystadenoma are present in up to 58% of cases, and transformation to borderline or malignant carcinoma is common [6,7,8]. Decisions regarding the treatment of mucinous cystadenoma need to be made proactively depending on the histologic classification

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call